These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23234235)

  • 61. Leishmanicidal activity of Nystatin (mycostatin): a potent polyene compound.
    Ali SA; Iqbal J; Nabeel ; Khalil Y; Manzoor A; Bukhari I; Ahmad B; Yasinzai MM
    J Pak Med Assoc; 1997 Oct; 47(10):246-8. PubMed ID: 9529849
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments.
    Lincopan N; Mamizuka EM; Carmona-Ribeiro AM
    J Antimicrob Chemother; 2005 May; 55(5):727-34. PubMed ID: 15761070
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
    Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME
    Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antifungal activity of amphotericin B conjugated to carbon nanotubes.
    Benincasa M; Pacor S; Wu W; Prato M; Bianco A; Gennaro R
    ACS Nano; 2011 Jan; 5(1):199-208. PubMed ID: 21141979
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mannosylated liposomes bearing Amphotericin B for effective management of visceral Leishmaniasis.
    Rathore A; Jain A; Gulbake A; Shilpi S; Khare P; Jain A; Jain SK
    J Liposome Res; 2011 Dec; 21(4):333-40. PubMed ID: 21612342
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enhancing Safety and Efficacy by Altering the Toxic Aggregated State of Amphotericin B in Lipidic Nanoformulations.
    Das S; Devarajan PV
    Mol Pharm; 2020 Jun; 17(6):2186-2195. PubMed ID: 32324420
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Study of the toxicity of a new lipid complex formulation of amphotericin B.
    Larabi M; Pages N; Pons F; Appel M; Gulik A; Schlatter J; Bouvet S; Barratt G
    J Antimicrob Chemother; 2004 Jan; 53(1):81-8. PubMed ID: 14657087
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of the leishmanicidal activity of fungizone, liposomal AmB and amphotericin B incorporated into egg lecithin-bile salt mixed micelles.
    Ramos H; Brajtburg J; Marquez V; Cohen BE
    Drugs Exp Clin Res; 1995; 21(6):211-6. PubMed ID: 8907695
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential internalization of amphotericin B--conjugated nanoparticles in human cells and the expression of heat shock protein 70.
    Paulo CS; Lino MM; Matos AA; Ferreira LS
    Biomaterials; 2013 Jul; 34(21):5281-93. PubMed ID: 23578560
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Emulsion of amphotericin B in Intralipid 20%: in vitro and in vivo efficacy].
    Chavanet P; Charlier N; Brenet A; Goux A; Muggéo E; Caillot D; Casasnovas O; Kistermann JP; Waldner A; Portier H
    Pathol Biol (Paris); 1992 May; 40(5):507-12. PubMed ID: 1495835
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate.
    Thakur CP; Thakur S; Narayan S; Sinha A
    Indian J Med Res; 2008 Jun; 127(6):582-8. PubMed ID: 18765878
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Thiolated PVP-Amphotericin B Complexes: An Innovative Approach toward Highly Mucoadhesive Gels for Mucosal Leishmaniasis Treatment.
    Jalil A; Asim MH; Shahzadi I; Khan M; Matuszczak B; Bernkop-Schnürch A
    Biomacromolecules; 2020 Sep; 21(9):3658-3667. PubMed ID: 32803961
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Topical Amphotericin B Semisolid Dosage Form for Cutaneous Leishmaniasis: Physicochemical Characterization, Ex Vivo Skin Permeation and Biological Activity.
    Berenguer D; Alcover MM; Sessa M; Halbaut L; Guillén C; Boix-Montañés A; Fisa R; Calpena-Campmany AC; Riera C; Sosa L
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32059430
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyaluronic acid-amphotericin B nanocomplexes: a promising anti-leishmanial drug delivery system.
    Silva-Carvalho R; Leão T; Bourbon AI; Gonçalves C; Pastrana LM; Parpot P; Amorim I; Tomás AM; Gama FM
    Biomater Sci; 2022 Apr; 10(8):1952-1967. PubMed ID: 35253814
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Noncovalent Complexation of Amphotericin B with Poly(β-Amino Ester) Derivates for Treatment of
    Yu Y; Peng L; Liao G; Chen Z; Li C
    Polymers (Basel); 2019 Feb; 11(2):. PubMed ID: 30960254
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased calcium permeability is not responsible for the rapid lethal effects of amphotericin B on Leishmania sp.
    Cohen BE; Benaim G; Ruiz MC; Michelangeli F
    FEBS Lett; 1990 Jan; 259(2):286-8. PubMed ID: 2294016
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antileishmanial Activity and Synergistic Effects of Amphotericin B Deoxycholate with Allicin and Andrographolide against
    Intakhan N; Chanmol W; Somboon P; Bates MD; Yardley V; Bates PA; Jariyapan N
    Pathogens; 2020 Jan; 9(1):. PubMed ID: 31936536
    [No Abstract]   [Full Text] [Related]  

  • 78. Impact of aldehyde content on amphotericin B-dextran imine conjugate toxicity.
    Sokolsky-Papkov M; Domb AJ; Golenser J
    Biomacromolecules; 2006 May; 7(5):1529-35. PubMed ID: 16677035
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Distinct cytokine release profiles from human endothelial and THP-1 macrophage-like cells exposed to different amphotericin B formulations.
    Turtinen LW; Bremer LA; Prall DN; Schwartzhoff J; Hartsel SC
    Immunopharmacol Immunotoxicol; 2005; 27(1):85-93. PubMed ID: 15803862
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Covalent Conjugation of Amphotericin B to Hyaluronic Acid: An Injectable Water-Soluble Conjugate with Reduced Toxicity and Anti-Leishmanial Potential.
    Silva-Carvalho R; Leão T; Gama FM; Tomás AM
    Biomacromolecules; 2022 Mar; 23(3):1169-1182. PubMed ID: 35025509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.